# Biospecimen logistics for clinical trials

What degrades at each temperature tier, why freezing damages even as it preserves, the freeze-thaw problem, and why chain of custody is part of sample integrity rather than paperwork around it.

A biospecimen begins degrading the moment it leaves the body, at a rate set by temperature; logistics is the management of that chemical clock — and an unrecorded warm excursion destroys information as surely as a fast one.

Source: https://en.bioecon.ru/docs/services-governance-capital/logistics-supply-chain/biospecimen-logistics-for-clinical-trials/
Updated: 2026-09-07



A blood tube or tissue fragment leaves a regulated interior — buffered, temperature-controlled, patrolled by the immune system — and lands in a vial full of proteases, nucleases and, soon, dividing bacteria. Degradation starts at the needle, and it is not one process but many, running at different speeds: cells consume glucose and, dying, leak potassium into the plasma; ribonucleases shred RNA within minutes; proteins are cleaved and oxidized over hours to days. The value a laboratory reports is therefore never the concentration in the patient but the concentration after a stated history of time and temperature. Logistics is the management of that history.

## The temperature tiers

Each storage tier is a compromise between chemistry and physics. Chilled to 2–8 °C, enzymatic and microbial rates fall steeply — roughly halving over each ten-degree drop — which buys most analytes days; but nothing stops, cells keep dying and leaking, and some assays are ruined by the cold itself. Frozen solid at about −80 °C, enzymatic activity nearly halts — but freezing is not neutral preservation. As water crystallizes it excludes solutes, so everything dissolved concentrates in narrow unfrozen channels: pH shifts, salts reach aggressive strengths, and ice crystals mechanically shear membranes and organelles. Preservation and damage are the same event. Viable cells therefore go colder still, into liquid-nitrogen vapor below −150 °C, where the residual concentrate vitrifies — becomes a glass — and molecular motion drops to that of a solid; below the glass transition, diffusion effectively ends, and the clock, for practical purposes, stops.

## The freeze-thaw problem

Thawing re-liquefies the most damaged fraction of the sample — those concentrated channels — and every reaction that freezing slowed now runs at once, on concentrated reactants. Refreezing repeats the crystal damage. Degradation per cycle is disproportionate to any per-degree argument, which is why the discipline splits samples into single-use aliquots at first draw: the standard is not "kept frozen" but "thawed once, by design." A single unmonitored warm excursion does worse than degrade — it makes the sample uninterpretable, because no one can any longer separate the changes the disease made from the changes the journey made. This is why temperature logging is part of the measurement itself, not an accessory to it.

## Custody as integrity

The same logic extends from chemistry into identity. A result becomes data only if it attaches, traceably and end to end, to the right patient, consent and protocol; a specimen of perfect chemical integrity with a broken chain of custody is worse than worthless — it injects confident error into the dataset. Custody controls are to information what the cold chain is to molecules: a defense against irreversible corruption that no downstream measurement can repair. The transport page for [hazardous biomaterials](../hazardous-biomaterials-transport/) faces the converse problem — keeping the contents away from people; here the asset being kept intact is the information inside them. Where the journey ends in years of storage rather than hours of transport, the same clock keeps running: [biobanks](../../../health-biomedicine/diagnostics-medtech/biobanks-human-population-samples/) live or die by the same preanalytical arithmetic.